<noscript id="2mmmm"><acronym id="2mmmm"></acronym></noscript>
  • <tt id="2mmmm"></tt>
  • <tt id="2mmmm"><rt id="2mmmm"></rt></tt>
  • <table id="2mmmm"></table>
  • <tt id="2mmmm"><rt id="2mmmm"></rt></tt>
    <tt id="2mmmm"><table id="2mmmm"></table></tt>
    中文
    中文
    為了病患而驅動(dòng)的創(chuàng )新
    Patient-first cell therapy innovation

    2020
    • 0
    Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models.
    OncoImmunology 9(1):1806009. (*: Corresponding authors, PMCID: PMC7458607)
    Qin D., Li D., Zhang B., Chen Y., Liao X., Li X., Alexander P.B., Wang Y.,* Li Q.-J.* (2020)


    T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma.
    OncoImmunology, 9(1):1749476. (PMCID: PMC7153824)
    Zhang Y., Mudgal P., Wang L., Wu H., Huang N., Alexander P.B., Gao Z., Ji N. & Li Q.-J. (2020)
    03.23
    2022
    來(lái)源:
    關(guān)鍵詞:
    相關(guān)閱讀

    Copyright ? 2019 天科雅生物醫藥科技有限公司

    粵公網(wǎng)安備 44011502000528號

    粵ICP備20056630號 Powered by vancheer
    關(guān)于天科雅
    研究與發(fā)展
    產(chǎn)品及臨床
    新聞與媒體
    招賢納士

    Copyright ? 2019 天科雅生物醫藥科技有限公司

    粵公網(wǎng)安備 44011502000528號

    粵ICP備20056630號 Powered by vancheer
    精品无码国产自产在线观看水浒传_西西人体444WwW高清大胆_国产探花在线精品一区二区_成人试看120秒体验区